Management [ocac]
Female sexual dysfunction [mobd]
postmenopausal [tmco]
Women [popg]
Testosterone [horm, phsu, strd]
Administration [ocac]
Safety Issues [inpo]
controversies [socb]
Introduction [hlca]
Food and Drug Administration [hcro]
Group [idcn]
Question [inpr]
Safety [hcpp]
Testosterone [horm, phsu, strd]
Administration [ocac]
postmenopausal [tmco]
Women [popg]
Short-term [tmco]
Exist [cnce]
Safety [hcpp]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Trial [resa]
Testosterone [horm, phsu, strd]
Concern [idcn]
Safety Issues [inpo]
Exist [cnce]
Literature [inpr]
Published [ocac]
Concern [idcn]
Safety [hcpp]
Administration [ocac]
Testosterone [horm, phsu, strd]
Women [popg]
Methods [inpr]
Published [ocac]
Article [inpr]
Identified [qlco]
search [inpr]
ovid [mamm]
Databases [inpr]
bibliographies [inpr, mnob]
Article [inpr]
Identified [qlco]
TOPIC [ftcn]
Testosterone [horm, phsu, strd]
Androgen [horm, phsu]
treatment [ftcn]
Women [popg]
Adverse reactions [fndg]
Exogenous [spco]
Androgens [horm, phsu]
Expected [idcn]
Androgen Effect [phsf]
Side [spco]
Hirsutism [fndg]
Acne [dsyn]
High density lipoprotein [aapp, bacs, lipd]
Decreased [qnco]
Oral [spco]
Androgens [horm, phsu]
Insufficient [qlco]
Safety [hcpp]
Breast [bpoc]
Endometrium [bpoc]
Heart [bpoc]
Safety [hcpp]
Draw [inpr]
Strong [qlco]
Conclusions [idcn]
Available [ftcn]
Date [tmco]
Reassuring [hlca]
Conclusions [idcn]
Testosterone [horm, phsu, strd]
Administration [ocac]
postmenopausal [tmco]
Women [popg]
Physiological [ftcn]
Slightly [idcn]
Serum testosterone level [lbpr]
free [ftcn]
